<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/340C86AC-7DFE-4531-B18E-2D2AEE735A1E"><gtr:id>340C86AC-7DFE-4531-B18E-2D2AEE735A1E</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>Sissons</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BBD65048-AED3-4824-ACD7-DEA6923DA9C3"><gtr:id>BBD65048-AED3-4824-ACD7-DEA6923DA9C3</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Sinclair</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9202171"><gtr:id>95AF4944-A008-4C55-96F5-8709B2035C7E</gtr:id><gtr:title>Biology of cytomegalovirus in the human host: cellular and immunological control</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9202171</gtr:grantReference><gtr:abstractText>Human cytomegalovirus (HCMV) is a virus which is carried without symptoms by the majority of the population. However, it can cause serious disease in infants born to mothers who acquire the infection in pregnancy and in people whose immune system is suppressed. Understanding how the virus succeeds in maintaining itself in most people without causing disease and how this relationship breaks down to cause disease should help develop better methods of treating the virus and of designing a vaccine (there is currently no vaccine available). Our research is aimed at determining (i) how the virus gains control of the cell in order to reproduce itself (ii) the mechanism by which the virus maintains silent infection ( latency ) in specialised cells of the immune system and the factors that reawake it and (iii) how the immune system controls the infection in normal people. We shall then extend our work to try and generate useful immune responses in patients at risk of infection. In addition to advancing our understanding of HCMV in particular, this research may also lead to a better understanding of other virus infections which persist in the body, and how the human host controls them.</gtr:abstractText><gtr:technicalSummary>This programme of research focuses on human cytomegalovirus (HCMV) a ubiquitous human herpesvirus which is a major cause of morbidity, especially in the immunocompromised host.
Understanding the molecular interactions between the virus and the cell which maintain latency and permit reactivation, and how the immune response then limits dissemination, are fundamental to understanding viral pathogenesis. Myeloid lineage cells are now established as being of major importance in carriage of the virus in vivo: our work has now shown that their differentiation to dendritic cells plays an integral role in reactivation of latent HCMV, and that human dendritic cells are a tractable model system in which to analyse reactivation of endogenous latent virus. The proposed work will concentrate on three main areas: (i) The mechanism by which differentiation-specific cellular factors maintain latency by repressing lytic gene expression in myeloid cells and the means by which the major viral lytic genes, once expressed, interdict in normal cell cycle control. (ii) The analysis of latency and reactivation of endogenous HCMV in a new model system we have identified, dendritic cells. (iii) The mechanism by which CD8+ T cell memory to HCMV is generated in primary infection and subsequently maintained, and how expression of specific HCMV proteins may influence and modulate the response. This work should lead to a more detailed understanding of virus latency and reactivation in the human host and hence to more rational interventional strategies.</gtr:technicalSummary><gtr:fund><gtr:end>2008-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1993-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3047120</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cleveland Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Cleveland Clinic Foundation</gtr:department><gtr:description>Analysis of latency-associated transcripts</gtr:description><gtr:id>2C8B1A68-636D-4DC0-800E-A6B556126716</gtr:id><gtr:impact>Betty Lau, Emma Poole, Ellen Van Damme, Lieve Bunkens, Madeleine Sowash, Harry King, Eain Murphy, Mark Wills, Marnix Van Loock, John Sinclair 2016. Human cytomegalovirus miR-UL112-1 promotes the down-regulation of viral immediate early gene expression during latency to prevent T cell recognition of latently infected cells Published ahead of print 10.1099/jgv.0.000546
 Betty Lau, Emma Poole, Benjamin Krishna, Immaculada Sellart, Mark R. Wills, Eain Murphy, and&amp;not; John Sinclair (2016) The Expression of Human Cytomegalovirus MicroRNA MiR-UL148D during Latent Infection in Primary Myeloid Cells Inhibits Activin A-triggered Secretion of IL-6. Sci Rep. 6 :31205, doi:10.1038/srep31205</gtr:impact><gtr:outcomeId>77868117C59-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators helped us to define latent transcripts further work on which was funded by an MRC Programme Grant renewal</gtr:partnerContribution><gtr:piContribution>Our research led to the detection of certain viral genes during latent infection</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Weizmann Institute of Science</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>Single Cell RNAseq of latently infected cells</gtr:description><gtr:id>3C863C91-131E-4970-82BA-D6D1DF7D3382</gtr:id><gtr:impact>None, yet</gtr:impact><gtr:outcomeId>58be7dd73e1207.38363014-1</gtr:outcomeId><gtr:partnerContribution>RNA sequencing of latently infected cells</gtr:partnerContribution><gtr:piContribution>We provide sorted latently infected CD34 and CD14 positive cells for RNAseq</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Oral presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC722B7B-4897-4467-A3BA-62D155A22843</gtr:id><gtr:impact>University of Cambridge Science Festival

Dissemination of the research to the public</gtr:impact><gtr:outcomeId>ABE2AD9F7B1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Cambridge Public Understanding of Science</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5B0371EA-BFC3-48A9-A052-5ADD4ED4ED80</gtr:id><gtr:impact>Lecture to attendees

None</gtr:impact><gtr:outcomeId>C14E0A65427</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme grant renewal</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0701279</gtr:fundingRef><gtr:id>D3EFA6D6-83D6-4784-8571-311376B20FE8</gtr:id><gtr:outcomeId>VJTCU11FwBN</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>CD34+ progenitor cells latently infected with cytomegalovirus</gtr:description><gtr:id>C0A6C935-0097-4142-A025-59A6AD1DC34A</gtr:id><gtr:impact>Other research groups are using thsi model system</gtr:impact><gtr:outcomeId>168582D9163</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Model sysytems for cytomegalovirus latency</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Recombinant viral mutants deficient in latent gene expression</gtr:description><gtr:id>1E564DF8-3AFC-4154-84FD-ACFADED2B4D3</gtr:id><gtr:impact>none as yet</gtr:impact><gtr:outcomeId>640553AEB7B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mutant viruses</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>New targets to detect latently infected cells by PCR</gtr:description><gtr:id>1B669007-9529-4098-8886-414433381E7C</gtr:id><gtr:impact>none as yet</gtr:impact><gtr:outcomeId>0B6F5DC0559</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Novel detection systems for latent infection</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>AC793D74-FE10-43A1-AC9A-4EEA2C8A4CB4</gtr:id><gtr:title>The cellular protein MCM3AP is required for inhibition of cellular DNA synthesis by the IE86 protein of human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bdc40f0f8c6b621c5ccc76e7dcc36da"><gtr:id>4bdc40f0f8c6b621c5ccc76e7dcc36da</gtr:id><gtr:otherNames>Poole E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12893_23_23094019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>958F77F0-4D3F-4FB3-8C48-B90C3025B35F</gtr:id><gtr:title>Control of cytomegalovirus lytic gene expression by histone acetylation.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d0e9d024cbc82c6cd7c81eb135cc25c"><gtr:id>2d0e9d024cbc82c6cd7c81eb135cc25c</gtr:id><gtr:otherNames>Murphy JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_12893_13_11867539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F26CF3F-A205-4658-9588-3FCCD26A9407</gtr:id><gtr:title>Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death.</gtr:title><gtr:parentPublicationTitle>European journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73261f28b1d5f3e7bbb405c01736b667"><gtr:id>73261f28b1d5f3e7bbb405c01736b667</gtr:id><gtr:otherNames>Bain M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0171-9335</gtr:issn><gtr:outcomeId>pm_12893_13_16003908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>694F340E-0895-491E-8C59-2C51C7A43558</gtr:id><gtr:title>A novel neuroprotective therapy for Parkinson's disease using a viral noncoding RNA that protects mitochondrial complex I activity.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93af7377184cdebbd9a735f34f7d49a3"><gtr:id>93af7377184cdebbd9a735f34f7d49a3</gtr:id><gtr:otherNames>Kuan WL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_12893_23_22184634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9993BAB1-8713-43D5-8696-28DBDBDBE082</gtr:id><gtr:title>Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b895d6f1022449850bff9b154540eb7"><gtr:id>6b895d6f1022449850bff9b154540eb7</gtr:id><gtr:otherNames>Weekes MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>6098C98D8CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>643C98AC-3CEA-4212-8C3F-95B69D6CA8E1</gtr:id><gtr:title>Latency and reactivation of human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/880c79b4b226cab99274f0fae7128192"><gtr:id>880c79b4b226cab99274f0fae7128192</gtr:id><gtr:otherNames>Sinclair J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_13_16760381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F85E2E3B-E530-4C7F-AFB9-33CE4DA1694F</gtr:id><gtr:title>Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28e62693630159f438f57ac06f537767"><gtr:id>28e62693630159f438f57ac06f537767</gtr:id><gtr:otherNames>Hagemeier C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_12893_893_8026474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0AFBCE6-95C5-457C-9C07-E1228BC44E99</gtr:id><gtr:title>The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbcad82585b37e480939c9b187de13c5"><gtr:id>fbcad82585b37e480939c9b187de13c5</gtr:id><gtr:otherNames>Cano F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_12893_23_22863774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>855F4C36-F527-4364-938B-9B841638F0E0</gtr:id><gtr:title>An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_13_16227215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F876556-59B5-472D-9B55-8117CD36BE10</gtr:id><gtr:title>Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ac20894142731f9b0efe1c795b481ba"><gtr:id>1ac20894142731f9b0efe1c795b481ba</gtr:id><gtr:otherNames>Wills MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_12893_13_16301653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F7CACE2-7C8C-49F1-A80F-EDA192A2F883</gtr:id><gtr:title>Human cytomegalovirus infection inhibits epidermal growth factor (EGF) signalling by targeting EGF receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb6889134c3cf78d0dadd8131726b31f"><gtr:id>fb6889134c3cf78d0dadd8131726b31f</gtr:id><gtr:otherNames>Fairley JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_13_12388817</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B4511AA-4285-446C-BD68-97E12772B5A7</gtr:id><gtr:title>Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_12893_13_17540903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A246AF17-060C-47FC-A378-996B2871E183</gtr:id><gtr:title>Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/791088abb6d8f720eb8d8a2d54f14b85"><gtr:id>791088abb6d8f720eb8d8a2d54f14b85</gtr:id><gtr:otherNames>Huang MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_23_22647696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>181B9CFB-079D-4FAC-9EB8-DD7921EC6640</gtr:id><gtr:title>NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bdc40f0f8c6b621c5ccc76e7dcc36da"><gtr:id>4bdc40f0f8c6b621c5ccc76e7dcc36da</gtr:id><gtr:otherNames>Poole E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>FFEEC880F45</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFDC59D4-DA16-4E0A-A4A2-0335644CA611</gtr:id><gtr:title>Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8cc419a2f3be17568a098587458a0"><gtr:id>04c8cc419a2f3be17568a098587458a0</gtr:id><gtr:otherNames>Reeves M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_13_17005678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96AE5482-FB72-452A-8E5B-4DA3839D191E</gtr:id><gtr:title>Human cytomegalovirus and immunopathology.</gtr:title><gtr:parentPublicationTitle>Springer seminars in immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/987969a32b3867694431eeeac23dc547"><gtr:id>987969a32b3867694431eeeac23dc547</gtr:id><gtr:otherNames>Sissons JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0344-4325</gtr:issn><gtr:outcomeId>pm_12893_13_12503063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46147898-4711-474A-94D5-332DC4C1234A</gtr:id><gtr:title>NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72bde0b23544f96ac8d87c98118e1b63"><gtr:id>72bde0b23544f96ac8d87c98118e1b63</gtr:id><gtr:otherNames>Ashiru O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_13_19793804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFDACF84-BA8C-416B-B947-A0FC88B4F6EA</gtr:id><gtr:title>Human cytomegalovirus: Latency and reactivation in the myeloid lineage.</gtr:title><gtr:parentPublicationTitle>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/880c79b4b226cab99274f0fae7128192"><gtr:id>880c79b4b226cab99274f0fae7128192</gtr:id><gtr:otherNames>Sinclair J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1386-6532</gtr:issn><gtr:outcomeId>6949B875C1C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A17A538F-DEAC-46A1-B099-F2D52C030304</gtr:id><gtr:title>Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>gZLTnMZ8VYo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4216E8B7-1CE9-4EE5-82BD-86D94EDC017E</gtr:id><gtr:title>Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8cc419a2f3be17568a098587458a0"><gtr:id>04c8cc419a2f3be17568a098587458a0</gtr:id><gtr:otherNames>Reeves M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>RGrzJADJKv6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>198C6FD9-CB8B-44BC-BFA3-1E0A4CA90FD2</gtr:id><gtr:title>Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12893_13_15738399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C8C84E9-1A2E-4E75-A946-B0FC86D9E1CB</gtr:id><gtr:title>Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20d02bc2c32cfe6f4c97355b57afcfe4"><gtr:id>20d02bc2c32cfe6f4c97355b57afcfe4</gtr:id><gtr:otherNames>Thomas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12893_13_18230726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>297E8A12-0336-477C-8DCF-22840C02A26E</gtr:id><gtr:title>Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific &amp;quot;effector memory&amp;quot; (CD28(-) CD45RA(HI)) CD8(+) T cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e01291574513b806263a474c2963389e"><gtr:id>e01291574513b806263a474c2963389e</gtr:id><gtr:otherNames>Waller EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>7CD8BE4F7AD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F54289C6-92FC-49AA-804E-915876D802B1</gtr:id><gtr:title>Report from the second cytomegalovirus and immunosenescence workshop.</gtr:title><gtr:parentPublicationTitle>Immunity &amp; ageing : I &amp; A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bee66e5d800437620ae80666b3b0c95"><gtr:id>7bee66e5d800437620ae80666b3b0c95</gtr:id><gtr:otherNames>Wills M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4933</gtr:issn><gtr:outcomeId>pm_12893_23_22035114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32B05F47-B6F7-465C-8DA7-A364AB6364D4</gtr:id><gtr:title>Depletion of cellular pre-replication complex factors results in increased human cytomegalovirus DNA replication.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fb9a53ac3ff5ecb2d97e2de7a0894de"><gtr:id>1fb9a53ac3ff5ecb2d97e2de7a0894de</gtr:id><gtr:otherNames>Braun TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12893_23_22586460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B32BC03-6992-4CCF-A9BA-8EC45B22479D</gtr:id><gtr:title>Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e80b1419377cde6efeeb9dd3643949f"><gtr:id>6e80b1419377cde6efeeb9dd3643949f</gtr:id><gtr:otherNames>Minton EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_893_8189535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5277B226-DF66-408A-A08A-4AF443F51790</gtr:id><gtr:title>Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32b6fd424ed897ba81cdda71068dbb93"><gtr:id>32b6fd424ed897ba81cdda71068dbb93</gtr:id><gtr:otherNames>Caswell R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_893_8648740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E297CCC-342E-4678-A992-C96885A0B39B</gtr:id><gtr:title>Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f1fa95512c8c24498210be8597cb0d8"><gtr:id>6f1fa95512c8c24498210be8597cb0d8</gtr:id><gtr:otherNames>Reeves MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_13_15483249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84C7DD73-912B-42F0-8094-25305B8E3F6C</gtr:id><gtr:title>The co-speciation of human cytomegalovirus (HCMV) with its human host has enabled this human pathogen to evolve multiple mechanisms to allow it to be carried, generally sub-clinically, for the lifetime of the host in the face of a robust immune response. Preface.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bee66e5d800437620ae80666b3b0c95"><gtr:id>7bee66e5d800437620ae80666b3b0c95</gtr:id><gtr:otherNames>Wills M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>XxAF85TsKKF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAAAFF9B-878C-43E5-A2E3-33191A1A92B2</gtr:id><gtr:title>CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c8276cd9ba0736a8dcd0d7bab6d85ff"><gtr:id>3c8276cd9ba0736a8dcd0d7bab6d85ff</gtr:id><gtr:otherNames>Hayhurst GP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1995-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_793_7983709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B592F9B-0DFB-4861-9087-2772D6119DBE</gtr:id><gtr:title>Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc1c2fe0549d444ca1aa0c4981373034"><gtr:id>fc1c2fe0549d444ca1aa0c4981373034</gtr:id><gtr:otherNames>Taylor-Wiedeman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_893_8107221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F30B852-FC51-42FD-9384-3C706B990338</gtr:id><gtr:title>Reactivation of human cytomegalovirus in dendritic cells.</gtr:title><gtr:parentPublicationTitle>Discovery medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8cc419a2f3be17568a098587458a0"><gtr:id>04c8cc419a2f3be17568a098587458a0</gtr:id><gtr:otherNames>Reeves M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1539-6509</gtr:issn><gtr:outcomeId>pm_12893_23_20704905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23229788-7AA2-451F-9298-24A581081EA8</gtr:id><gtr:title>Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20d02bc2c32cfe6f4c97355b57afcfe4"><gtr:id>20d02bc2c32cfe6f4c97355b57afcfe4</gtr:id><gtr:otherNames>Thomas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_12893_13_18481981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94CE518B-2718-4BE5-ABCB-F2EE53EC0E05</gtr:id><gtr:title>Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b3bbe27015d9b0d2dedbe98dbf0e42a"><gtr:id>1b3bbe27015d9b0d2dedbe98dbf0e42a</gtr:id><gtr:otherNames>Ormiston ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>pm_12893_23_22832786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94925F0C-94FE-4777-9A29-CBE97198224B</gtr:id><gtr:title>Inhibition of human cytomegalovirus major immediate early gene expression by antisense RNA expression vectors.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a6235019499a9f26749825f92afab0b"><gtr:id>7a6235019499a9f26749825f92afab0b</gtr:id><gtr:otherNames>Bryant LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1993-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_893_8397287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C01A7076-E7E2-4E4F-918C-4685922FA34D</gtr:id><gtr:title>The S phase of the cell cycle and its perturbation by human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>Reviews in medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73261f28b1d5f3e7bbb405c01736b667"><gtr:id>73261f28b1d5f3e7bbb405c01736b667</gtr:id><gtr:otherNames>Bain M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1052-9276</gtr:issn><gtr:outcomeId>pm_12893_13_17676653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1752A224-F559-42C0-A663-43FCB73753FB</gtr:id><gtr:title>Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34? progenitors.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bdc40f0f8c6b621c5ccc76e7dcc36da"><gtr:id>4bdc40f0f8c6b621c5ccc76e7dcc36da</gtr:id><gtr:otherNames>Poole E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>iwJAJKEFRKb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68C5496A-115A-4F43-BD9C-C0B64452FD99</gtr:id><gtr:title>Dynamics of T cell memory in human cytomegalovirus infection.</gtr:title><gtr:parentPublicationTitle>Medical microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e01291574513b806263a474c2963389e"><gtr:id>e01291574513b806263a474c2963389e</gtr:id><gtr:otherNames>Waller EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-8584</gtr:issn><gtr:outcomeId>85B13ABB559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D205F72F-5ED0-496C-97F8-4DA6B035609C</gtr:id><gtr:title>Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ccc3c6c838a5ccf14afb533736d1029"><gtr:id>2ccc3c6c838a5ccf14afb533736d1029</gtr:id><gtr:otherNames>Day EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d4ead483739.97042236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>032E65BB-653C-4E20-AC7C-9874E50EB23D</gtr:id><gtr:title>Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b2264574061bca937ed1b2bad0e649e"><gtr:id>4b2264574061bca937ed1b2bad0e649e</gtr:id><gtr:otherNames>Mendelson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_993_9000102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AB5CFA5-A7E0-4C49-9062-9936EF841457</gtr:id><gtr:title>The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a6235019499a9f26749825f92afab0b"><gtr:id>7a6235019499a9f26749825f92afab0b</gtr:id><gtr:otherNames>Bryant LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_13_10906177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B02A54C7-83F7-45BD-8763-261FD6BA33C5</gtr:id><gtr:title>Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d1012177ac688501bbeff83469226f8"><gtr:id>3d1012177ac688501bbeff83469226f8</gtr:id><gtr:otherNames>Goodrum F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>4C648C8C7FD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F98B1640-BFC8-480A-BE64-9F99B1DD812A</gtr:id><gtr:title>Latent and persistent infections of monocytes and macrophages.</gtr:title><gtr:parentPublicationTitle>Intervirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/880c79b4b226cab99274f0fae7128192"><gtr:id>880c79b4b226cab99274f0fae7128192</gtr:id><gtr:otherNames>Sinclair J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:issn>0300-5526</gtr:issn><gtr:outcomeId>pm_12893_993_9130040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B99CA6DB-3034-4E6E-BD25-12D0C8F6DA9C</gtr:id><gtr:title>Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/480571fcfa950c333146811874d42270"><gtr:id>480571fcfa950c333146811874d42270</gtr:id><gtr:otherNames>Bennett NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_12893_23_20530255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58A7553D-724C-42AE-824F-157810A2CF6C</gtr:id><gtr:title>The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bdc40f0f8c6b621c5ccc76e7dcc36da"><gtr:id>4bdc40f0f8c6b621c5ccc76e7dcc36da</gtr:id><gtr:otherNames>Poole E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_12893_13_16932746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FE57064-463E-4EA0-9332-9981BB88A339</gtr:id><gtr:title>Manipulation of dendritic cell functions by human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>Expert reviews in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/880c79b4b226cab99274f0fae7128192"><gtr:id>880c79b4b226cab99274f0fae7128192</gtr:id><gtr:otherNames>Sinclair J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-3994</gtr:issn><gtr:outcomeId>DC8ED528C55</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BCC328E-02B3-4326-80E8-B588F8F02D8C</gtr:id><gtr:title>Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be4eba9249e5210879c5ba825b58c879"><gtr:id>be4eba9249e5210879c5ba825b58c879</gtr:id><gtr:otherNames>Mason GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12893_23_22826250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06D8A8F3-9B1D-4F6B-9A04-56BD15CE08FD</gtr:id><gtr:title>Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09f2556974ea3a7cf82fcccaa4a9c588"><gtr:id>09f2556974ea3a7cf82fcccaa4a9c588</gtr:id><gtr:otherNames>Baillie J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12893_13_12768019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E56A64FF-A06E-42BE-965E-79B8FE8C9C0A</gtr:id><gtr:title>Human cytomegalovirus modulation of CCR5 expression on myeloid cells affects susceptibility to human immunodeficiency virus type 1 infection.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c8d8cedd6e96a3bbb52cd46c9b30bc5"><gtr:id>3c8d8cedd6e96a3bbb52cd46c9b30bc5</gtr:id><gtr:otherNames>King CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_13_16847113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BFB126C-DEF1-483F-A5A8-AC3EAA748E40</gtr:id><gtr:title>Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/880c79b4b226cab99274f0fae7128192"><gtr:id>880c79b4b226cab99274f0fae7128192</gtr:id><gtr:otherNames>Sinclair J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_13_10811939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E394F6F0-5AAE-4744-874B-A96031BC2B47</gtr:id><gtr:title>Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d31e7ea7adf9e526eb0cc9cb07ec201d"><gtr:id>d31e7ea7adf9e526eb0cc9cb07ec201d</gtr:id><gtr:otherNames>Woodhall DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12893_13_17035242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C40182F-8ECF-4E77-B54C-08B01808B649</gtr:id><gtr:title>Ets-2 repressor factor recruits histone deacetylase to silence human cytomegalovirus immediate-early gene expression in non-permissive cells.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/654a6d10a06f182dd8f0d98e126c3340"><gtr:id>654a6d10a06f182dd8f0d98e126c3340</gtr:id><gtr:otherNames>Wright E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_13_15722512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5C6C19A-193F-4CF0-9530-0A3C5070347F</gtr:id><gtr:title>Immunosenescence and Cytomegalovirus: where do we stand after a decade?</gtr:title><gtr:parentPublicationTitle>Immunity &amp; ageing : I &amp; A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3d7b94b96c564cc8d50398b265aff7d"><gtr:id>e3d7b94b96c564cc8d50398b265aff7d</gtr:id><gtr:otherNames>Pawelec G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4933</gtr:issn><gtr:outcomeId>YFm3XbPFTid</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F95A67D-DB1B-46A8-A919-58694F5E6B4D</gtr:id><gtr:title>Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/880c79b4b226cab99274f0fae7128192"><gtr:id>880c79b4b226cab99274f0fae7128192</gtr:id><gtr:otherNames>Sinclair J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>C466288D864</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E4BFD3C-4CCB-45C2-AB84-325F07877B5C</gtr:id><gtr:title>Cytomegalovirus beta2.7 RNA transcript protects endothelial cells against apoptosis during ischemia/reperfusion injury.</gtr:title><gtr:parentPublicationTitle>The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11e74e5a3a7b3794a49aa81194f3c27f"><gtr:id>11e74e5a3a7b3794a49aa81194f3c27f</gtr:id><gtr:otherNames>Zhao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-2498</gtr:issn><gtr:outcomeId>iF9oJtLbv9o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD453BE3-D3DC-41ED-BCCB-1096D2EB4767</gtr:id><gtr:title>Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc1c2fe0549d444ca1aa0c4981373034"><gtr:id>fc1c2fe0549d444ca1aa0c4981373034</gtr:id><gtr:otherNames>Taylor-Wiedeman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1993-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_893_8381466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2304FFA-267E-47CC-9A59-0486CF4BD25E</gtr:id><gtr:title>Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8 T cell recognition.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd0fe58d15c91a83060bab38570801b7"><gtr:id>cd0fe58d15c91a83060bab38570801b7</gtr:id><gtr:otherNames>Besold K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>J4cPYt3PUKd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8F44562-6AF6-4F35-A4EF-BBB4B141DE38</gtr:id><gtr:title>The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45c595de895539621f32fbbeba5a634b"><gtr:id>45c595de895539621f32fbbeba5a634b</gtr:id><gtr:otherNames>Liu R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_12893_893_8041605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A86F65F5-D42F-49CF-8C4D-09EC6EDBCFB3</gtr:id><gtr:title>Human cytomegalovirus immunity and immune evasion.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14b5466875d526da0c1bf7e2cb63a0d5"><gtr:id>14b5466875d526da0c1bf7e2cb63a0d5</gtr:id><gtr:otherNames>Jackson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>kza83WqNCdu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D93A7E06-20C8-469F-A959-EDD3A2ACB0B5</gtr:id><gtr:title>Lytic infection of permissive cells with human cytomegalovirus is regulated by an intrinsic 'pre-immediate-early' repression of viral gene expression mediated by histone post-translational modification.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f06bcf853a3b3f2f7c17989d10224b85"><gtr:id>f06bcf853a3b3f2f7c17989d10224b85</gtr:id><gtr:otherNames>Groves IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>A3D71290BAA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A395726A-46C7-4F70-B893-168C8220696F</gtr:id><gtr:title>Ets-2 Repressor Factor (ERF) mediates repression of the human cytomegalovirus major immediate-early promoter in undifferentiated non-permissive cells.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73261f28b1d5f3e7bbb405c01736b667"><gtr:id>73261f28b1d5f3e7bbb405c01736b667</gtr:id><gtr:otherNames>Bain M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_13_12533699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA3F148B-F716-4B34-8FBB-4F3AB06C9B96</gtr:id><gtr:title>The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32b6fd424ed897ba81cdda71068dbb93"><gtr:id>32b6fd424ed897ba81cdda71068dbb93</gtr:id><gtr:otherNames>Caswell R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1993-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_12893_893_8277274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6F4E5EB-0D0F-433C-9CF0-CD951FF74DF4</gtr:id><gtr:title>Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bdc40f0f8c6b621c5ccc76e7dcc36da"><gtr:id>4bdc40f0f8c6b621c5ccc76e7dcc36da</gtr:id><gtr:otherNames>Poole E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>3BB6FD58C82</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99BE592D-DB3E-4170-90F0-F3FDCD54C4AA</gtr:id><gtr:title>Inhibition of epidermal growth factor receptor (EGFR) expression by human cytomegalovirus correlates with an increase in the expression and binding of Wilms' Tumour 1 protein to the EGFR promoter.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df2cb9d1519b99ab8eccc7589d52df06"><gtr:id>df2cb9d1519b99ab8eccc7589d52df06</gtr:id><gtr:otherNames>Jafferji I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>51964360A3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>606F260A-4AB4-49FC-917A-2B64EA8D0521</gtr:id><gtr:title>Aspects of human cytomegalovirus latency and reactivation.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8cc419a2f3be17568a098587458a0"><gtr:id>04c8cc419a2f3be17568a098587458a0</gtr:id><gtr:otherNames>Reeves M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>pm_12893_13_18637513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CF25AAB-683A-4548-8330-98F8B2A4F9D6</gtr:id><gtr:title>Knockdown of hDaxx in normally non-permissive undifferentiated cells does not permit human cytomegalovirus immediate-early gene expression.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f06bcf853a3b3f2f7c17989d10224b85"><gtr:id>f06bcf853a3b3f2f7c17989d10224b85</gtr:id><gtr:otherNames>Groves IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>F12AFD6C5C0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9202171</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>